Learn More About the PROSERA Study
Now enrolling: The PROSERA phase 3 study of seralutinib in adults with pulmonary arterial hypertension.
Effects of Inhaled Seralutinib on Right Ventricular Pulmonary Arterial Coupling and Right Heart Function in Pulmonary Arterial Hypertension